— Know what they know.
Not Investment Advice
Also trades as: GSK (NYSE) · $vol 208M · GSK.L (LSE) · $vol 186M · GS7.DE (XETRA) · $vol 2M

GLAXF OTC

GSK plc
1W: +5.6% 1M: +7.1% 3M: -1.7% YTD: +11.5% 1Y: +21.0% 3Y: +61.5% 5Y: +30.3%
$26.12
+1.22 (+4.90%)
 
OTC · Healthcare · Drug Manufacturers - General · Tech Score Buy · Power 60 · $104.7B mcap · 3.88B float · 0.0000% daily turnover · Short 54% of daily vol
Credit Risk of going bust: lower than 78% of companies Debt: 19.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.42 (down 98%), GSK plc would be worth roughly what it owes.
Total debt $24.13B against a stock market value of $102.18B.
Distance to default 9.19 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $14.90B (short-term plus half of long-term), stock volatility 25.7%; Altman Z'' 1.49. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
Oct 26, 2026
DCF
5
ROE
5
ROA
5
D/E
1
P/E
3
P/B
2
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GLAXF receives an overall rating of A-. Strongest factors: DCF (5/5), ROE (5/5), ROA (5/5). Areas of concern: D/E (1/5), P/B (2/5).
Rating Change History
DateFromTo
2026-09-25 B+ A-
2026-08-11 A- B+
2026-06-30 None ADDED
2026-06-30 EXISTED None
2026-06-24 B+ A-
2026-06-23 None ADDED
2026-06-23 EXISTED None
2026-06-18 A- B+
2026-06-16 B+ A-
2026-06-15 A- B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A
Profitability
56
Balance Sheet
55
Earnings Quality
63
Growth
63
Value
—
Momentum
88
Safety
—
Cash Flow
77

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
—
—
Piotroski F-Score
7/9
✓ ✓ ✓ ✓ ✗ ✗ ✓ ✓ ✓
Beneish M-Score
-2.69
Unlikely Manipulator
Ohlson O-Score
-7.53
Bankruptcy prob: 0.1%
Low Risk
Credit Rating
A
Score: 72.5/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 1.82x
Accruals: -6.5%
The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GLAXF scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GLAXF's score of -2.69 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GLAXF's implied 0.1% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GLAXF receives an estimated rating of A (score: 72.5/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). GLAXF's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
16.03x
PEG
0.37x
P/S
2.32x
P/B
4.38x
P/FCF
—
P/OCF
—
EV/EBITDA
—
EV/Revenue
—
EV/EBIT
—
EV/FCF
—
Earnings Yield
—
FCF Yield
—
Shareholder Yield
—
Graham Number
$10.73
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 16.0x earnings, GLAXF trades at a reasonable valuation. Graham's intrinsic value formula yields $10.73 per share, 143% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.817
NI / EBT
×
Interest Burden
0.698
EBT / EBIT
×
EBIT Margin
0.255
EBIT / Rev
×
Asset Turnover
0.551
Rev / Assets
×
Equity Multiplier
3.731
Assets / Equity
=
ROE
29.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GLAXF's ROE of 29.8% is driven by financial leverage (equity multiplier: 3.73x). Note: high leverage means ROE is amplified by debt rather than operational performance.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$45.69
Price/Value
—
Margin of Safety
—
Premium
—
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with GLAXF's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. GLAXF trades at a premium to its adjusted intrinsic value of $45.69, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 16.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$26.12
Median 1Y
$24.57
5th Pctile
$12.10
95th Pctile
$50.41
Ann. Volatility
45.4%
25th–75th percentile 5th–95th percentile Median path Historical

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
94,066
+37.1% YoY
Revenue / Employee
$347,221
Rev: $32,661,706,000
Profit / Employee
$60,756
NI: $5,715,074,000
SGA / Employee
$95,885
Avg labor cost proxy
R&D / Employee
$79,803
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
ROE 30.4% 30.9% 34.2% 30.0% 1.2% 1.2% 1.0% 1.1% 54.2% 41.2% 34.9% 29.8% 18.5% 19.1% 22.5% 23.5% 36.4% 38.0% 36.4% 29.8% 29.84%
ROA 5.7% 5.7% 6.3% 5.7% 20.4% 21.4% 19.7% 20.7% 10.0% 8.3% 7.7% 6.9% 4.2% 4.3% 5.3% 5.8% 9.2% 9.5% 9.4% 8.0% 8.00%
ROIC 15.2% 16.6% 18.7% 18.2% 21.7% 25.1% 21.2% 23.3% 26.3% 24.2% 22.4% 21.2% 16.8% 15.3% 15.6% 39.5% 21.3% 21.6% 20.1% 17.3% 17.35%
ROCE 9.6% 9.5% 8.9% 11.1% 14.0% 17.3% 16.5% 19.6% 21.0% 17.9% 16.0% 15.1% 10.8% 10.9% 12.2% 13.5% 19.2% 20.4% 20.1% 21.2% 21.19%
Gross Margin 68.2% 61.4% 62.3% 68.6% 69.1% 69.7% 72.0% 73.1% 72.1% 71.0% 73.7% 73.6% 70.1% 68.5% 74.2% 72.9% 73.6% 69.4% 75.4% 75.4% 75.36%
Operating Margin 21.4% 9.4% 28.6% 15.6% 15.2% 25.3% 30.0% 29.8% 23.9% 13.1% 26.9% 25.2% 2.4% 8.6% 29.5% 25.3% 30.3% 11.2% 30.1% 5.7% 5.72%
Net Margin 15.1% 7.9% 18.4% 12.1% 1.4% 19.8% 21.4% 22.6% 18.0% 4.3% 14.2% 14.9% -0.7% 5.1% 21.6% 18.1% 23.6% 7.4% 22.8% 5.2% 5.17%
EBITDA Margin 32.3% 14.7% 27.8% 25.0% 27.7% 25.0% 39.6% 36.6% 31.3% 27.7% 28.1% 29.3% 14.6% 13.8% 41.2% 40.4% 39.3% 22.5% 36.4% 30.9% 30.94%
FCF Margin 14.7% 14.7% 19.1% 21.4% 20.9% 16.1% 9.4% 7.8% 10.7% 13.8% 16.4% 15.0% 13.8% 10.6% 11.6% 14.8% 18.5% 19.2% 19.1% 21.1% 21.07%
OCF Margin 24.1% 23.3% 27.9% 29.8% 27.2% 23.2% 16.9% 15.6% 18.5% 21.6% 24.2% 22.3% 22.2% 20.1% 20.6% 24.4% 26.7% 25.6% 25.5% 26.4% 26.40%
ROE 3Y Avg snapshot only 26.24%
ROE 5Y Avg snapshot only 45.82%
ROA 3Y Avg snapshot only 6.86%
ROIC 3Y Avg snapshot only 17.73%
ROIC Economic snapshot only 16.15%
Cash ROA snapshot only 14.30%
Cash ROIC snapshot only 26.94%
CROIC snapshot only 21.50%
NOPAT Margin snapshot only 17.00%
Pretax Margin snapshot only 17.78%
R&D / Revenue snapshot only 22.38%
SGA / Revenue snapshot only 27.81%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
P/E Ratio — — — — — — — — — — — — — — — — 15.66 — — — 16.029
P/S Ratio — — — — — — — — — — — — — — — — 2.67 — — — 2.321
P/B Ratio — — — — — — — — — — — — — — — — 5.33 — — — 4.376
P/FCF — — — — — — — — — — — — — — — — 14.45 — — — —
P/OCF — — — — — — — — — — — — — — — — 10.01 — — — —
EV/EBITDA — — — — — — — — — — — — — — — — 9.30 — — — —
EV/Revenue — — — — — — — — — — — — — — — — 3.12 — — — —
EV/EBIT — — — — — — — — — — — — — — — — 13.10 — — — —
EV/FCF — — — — — — — — — — — — — — — — 16.88 — — — —
Earnings Yield — — — — — — — — — — — — — — — — 6.4% — — — —
FCF Yield — — — — — — — — — — — — — — — — 6.9% — — — —
PEG Ratio snapshot only 0.374
Graham Number snapshot only $10.73
Leverage & Solvency
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Current Ratio 0.81 0.79 1.19 1.43 0.97 0.91 0.95 0.88 0.95 0.88 0.87 0.82 0.81 0.78 0.87 0.87 0.84 0.82 0.79 0.82 0.815
Quick Ratio 0.54 0.54 0.95 1.31 0.74 0.68 0.69 0.63 0.70 0.62 0.58 0.54 0.53 0.52 0.58 0.57 0.55 0.54 0.52 0.52 0.524
Debt/Equity 1.66 1.61 2.06 1.35 2.42 1.98 1.77 1.69 1.59 1.35 1.28 1.18 1.15 1.24 1.30 0.00 1.10 1.08 1.07 1.03 1.034
Net Debt/Equity 1.43 1.32 1.20 0.95 1.63 1.24 1.18 1.18 1.08 0.96 0.99 0.97 0.92 0.97 0.99 -0.24 0.89 0.87 0.88 0.86 0.858
Debt/Assets 0.33 0.31 0.37 0.25 0.37 0.35 0.36 0.36 0.34 0.31 0.30 0.29 0.28 0.29 0.30 0.00 0.29 0.29 0.30 0.30 0.295
Debt/EBITDA 2.43 2.94 3.76 2.52 2.76 2.48 2.46 2.29 2.13 1.77 1.88 1.85 2.06 2.55 2.40 0.00 1.64 1.52 1.69 1.70 1.697
Net Debt/EBITDA 2.10 2.41 2.18 1.77 1.86 1.55 1.64 1.60 1.45 1.26 1.44 1.52 1.65 1.99 1.81 -0.42 1.34 1.23 1.39 1.41 1.408
Interest Coverage 6.52 6.75 7.45 7.14 6.88 7.81 7.60 9.11 10.29 7.96 7.60 7.08 5.07 6.43 7.65 8.15 11.68 11.57 11.54 12.04 12.036
Equity Multiplier 5.10 5.25 5.54 5.44 6.59 5.68 4.96 4.69 4.63 4.42 4.23 4.04 4.14 4.35 4.29 4.01 3.80 3.73 3.52 3.50 3.499
Cash Ratio snapshot only 0.144
Debt Service Coverage snapshot only 15.189
Cash to Debt snapshot only 0.170
FCF to Debt snapshot only 0.386
Defensive Interval snapshot only 224.7 days
Efficiency & Turnover
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Asset Turnover 0.42 0.43 0.43 0.43 0.49 0.46 0.39 0.40 0.49 0.51 0.52 0.54 0.53 0.53 0.53 0.54 0.54 0.54 0.53 0.55 0.551
Inventory Turnover 1.75 1.97 2.10 2.26 2.20 1.93 1.55 1.68 1.65 1.59 1.53 1.52 1.54 1.61 1.53 1.52 1.48 1.55 1.47 1.44 1.437
Receivables Turnover 4.29 5.78 4.93 5.29 4.48 5.46 3.84 4.43 3.69 5.34 4.50 4.48 3.93 5.47 4.54 4.34 4.20 5.01 4.43 4.44 4.435
Payables Turnover 0.73 2.61 0.80 0.86 0.76 2.51 0.55 0.59 0.53 2.24 0.59 0.61 0.58 2.50 0.60 0.62 0.59 0.96 0.61 0.61 0.609
DSO 85 63 74 69 81 67 95 82 99 68 81 81 93 67 80 84 87 73 82 82 82.3 days
DIO 209 185 174 161 166 189 236 218 221 229 238 241 238 227 238 240 246 235 248 254 254.0 days
DPO 500 140 458 427 478 146 662 615 690 163 622 596 625 146 605 586 615 382 602 600 599.7 days
Cash Conversion Cycle -206 109 -210 -196 -230 111 -331 -315 -370 134 -303 -274 -294 148 -287 -261 -282 -74 -271 -263 -263.4 days
Fixed Asset Turnover snapshot only 3.334
Operating Cycle snapshot only 336.3 days
Cash Velocity snapshot only 10.767
Capital Intensity snapshot only 1.846
Growth (YoY)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue -2.7% 0.0% 12.5% 7.4% 2.2% -6.4% -20.3% -16.9% -13.0% -5.0% 5.7% 7.2% 5.6% 3.5% 2.6% 0.6% 2.7% 4.1% 4.0% 5.0% 4.97%
Net Income -29.2% -20.2% 1.1% 8.4% 2.1% 2.3% 1.7% 2.2% -57.5% -67.0% -69.3% -73.8% -58.4% -47.7% -29.7% -15.1% 1.2% 1.2% 84.9% 40.8% 40.84%
EPS -29.5% -21.1% 0.2% -13.8% 2.1% 2.2% 1.7% 3.0% -57.7% -67.2% -69.5% -74.0% -58.1% -47.3% -30.1% -14.9% 1.2% 1.2% 87.7% 42.5% 42.50%
FCF -16.7% -19.0% 25.7% 97.4% 45.5% 2.5% -60.9% -69.7% -55.6% -18.4% 85.2% 1.1% 36.4% -20.9% -27.9% -1.1% 37.9% 88.9% 72.3% 49.9% 49.94%
EBITDA 24.7% -19.6% -11.8% -13.0% -23.8% 2.9% -4.1% 6.8% 21.8% 20.1% 11.6% -2.4% -20.4% -34.3% -18.8% -6.0% 38.9% 74.3% 46.9% 23.9% 23.92%
Op. Income -26.2% -20.3% -2.1% 6.8% -6.3% 11.9% -14.9% 8.4% 34.7% 4.1% 14.5% -4.3% -35.2% -32.8% -28.6% -26.5% 44.5% 60.7% 54.8% 23.6% 23.57%
OCF Growth snapshot only 13.49%
Asset Growth snapshot only 3.44%
Equity Growth snapshot only 18.44%
Shares Change snapshot only -1.17%
Dividend Growth snapshot only 18.40%
Growth (CAGR)
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue 3Y 3.3% 3.4% 5.3% 3.6% 1.0% -1.9% -6.1% -5.7% -4.7% -3.8% -1.8% -1.5% -2.1% -2.8% -4.7% -3.6% -1.9% 0.8% 4.1% 4.2% 4.21%
Revenue 5Y 4.6% 4.1% 4.7% 3.4% 2.5% 1.1% -0.6% -0.5% -0.4% -0.3% -0.3% -0.2% -1.1% -1.5% -2.2% -2.0% -1.3% -0.9% 0.2% 0.2% 0.19%
EPS 3Y 33.5% 7.3% 10.1% -5.5% 45.1% 46.7% 38.6% 31.3% -2.4% -5.7% -5.8% -3.4% -17.9% -17.5% -16.5% -3.8% -27.2% -27.4% -26.3% -31.9% -31.92%
EPS 5Y 70.7% 37.1% 25.1% 13.6% 42.5% 56.3% 68.7% 55.2% 25.7% 5.6% 2.1% -2.5% -11.6% -11.4% -10.7% -12.9% -3.3% -0.4% 1.9% 1.8% 1.77%
Net Income 3Y 34.3% 8.2% 10.8% 2.4% 46.1% 47.6% 39.5% 32.1% -1.8% -5.0% -5.2% -2.8% -17.8% -17.5% -16.0% -10.4% -27.1% -27.4% -26.4% -32.1% -32.09%
Net Income 5Y 71.9% 38.1% 26.0% 19.8% 43.5% 57.7% 69.8% 56.2% 26.5% 6.3% 2.8% -1.8% -11.3% -11.1% -10.1% -12.5% -2.9% -0.1% 2.1% 1.9% 1.89%
EBITDA 3Y 22.6% 3.4% 1.9% -3.1% -6.9% -4.1% -2.5% 2.8% 5.0% -0.2% -1.9% -3.2% -9.6% -6.7% -4.6% -0.7% 10.4% 11.2% 10.0% 4.4% 4.38%
EBITDA 5Y 26.5% 13.2% 11.2% 7.8% 2.8% 6.1% 7.3% 9.8% 11.3% 6.5% 2.5% -1.0% -4.8% -7.0% -3.4% -0.1% 5.1% 2.6% 2.4% 1.1% 1.11%
Gross Profit 3Y 3.0% 3.0% 4.6% 3.1% 0.9% -0.8% -3.9% -3.1% -1.8% -0.8% 1.3% 1.5% 0.5% -0.2% -1.6% -0.4% 1.7% 3.4% 5.5% 5.4% 5.41%
Gross Profit 5Y 5.2% 3.9% 4.1% 3.1% 2.2% 1.5% 0.5% 0.7% 0.9% 1.2% 1.5% 1.8% 0.9% 0.5% -0.3% -0.2% 0.7% 1.1% 2.1% 2.2% 2.24%
Op. Income 3Y 12.8% 4.2% 8.8% 1.7% -3.4% -0.1% -6.2% -6.5% -2.3% -2.5% -1.5% 3.5% -6.5% -7.8% -11.4% -8.6% 8.0% 4.0% 8.2% -4.6% -4.55%
Op. Income 5Y 29.5% 19.0% 15.3% 12.5% 7.4% 11.2% 11.5% 10.6% 12.6% 5.7% 4.7% 1.8% -4.7% -7.0% -7.6% -10.5% -2.7% 0.0% 1.1% 0.1% 0.14%
FCF 3Y -2.8% -8.8% 2.6% 6.6% 2.3% -4.2% -23.6% -33.3% -18.7% -12.2% -3.1% 7.2% -4.1% -12.9% -19.5% -14.9% -5.8% 6.8% 32.0% 45.1% 45.08%
FCF 5Y 12.3% 3.9% 7.0% 10.3% 8.4% 1.8% -9.5% -14.7% -9.9% -8.7% -4.8% -5.4% -8.3% -10.7% -9.9% -9.6% 0.2% 0.2% 2.5% 12.8% 12.80%
OCF 3Y 3.9% -1.9% 7.3% 8.4% 2.2% -2.6% -16.1% -22.1% -12.0% -8.1% -1.6% 3.4% -4.8% -7.4% -13.8% -9.7% -2.5% 4.1% 19.4% 24.1% 24.11%
OCF 5Y 9.9% 4.1% 7.3% 8.7% 5.6% 1.4% -5.8% -8.1% -5.2% -4.9% -2.0% -3.2% -4.4% -4.7% -4.8% -4.4% 1.4% -0.2% 1.4% 6.7% 6.70%
Assets 3Y 10.3% 10.9% 12.9% 11.9% -10.2% -9.0% -11.4% -11.1% -9.1% -9.8% -9.2% -9.0% -9.6% -9.1% -12.2% -12.7% 0.6% 0.5% 2.4% 1.0% 1.02%
Assets 5Y 6.0% 6.0% 8.7% 8.9% 0.5% 1.3% 0.9% 0.6% 0.8% 0.3% -1.3% -1.8% -7.0% -5.7% -6.4% -6.9% -5.4% -5.3% -4.2% -4.5% -4.46%
Equity 3Y 51.1% 51.1% 59.2% 65.5% -8.0% -4.0% -3.4% -2.3% -2.8% -2.9% -2.4% -2.2% -3.2% -3.2% -4.4% -3.3% 20.8% 15.6% 14.7% 11.3% 11.34%
Book Value 3Y 50.1% 50.0% 58.1% 52.7% -8.7% -4.5% -4.0% -2.9% -3.4% -3.6% -3.0% -2.9% -3.4% -3.2% -4.9% 3.7% 20.7% 15.6% 14.8% 11.6% 11.63%
Dividend 3Y -0.4% -0.6% -0.5% -7.6% -2.6% -5.2% -9.1% -15.4% -15.3% -14.1% -10.3% -2.3% 0.7% 2.8% 2.7% 9.4% 5.0% 4.9% 4.7% 5.6% 5.65%
Growth Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Revenue Stability 0.87 0.89 0.75 0.75 0.74 0.23 0.01 0.00 0.00 0.02 0.03 0.05 0.33 0.66 0.43 0.44 0.36 0.25 0.03 0.02 0.021
Earnings Stability 0.75 0.81 0.78 0.48 0.67 0.66 0.71 0.57 0.37 0.21 0.17 0.09 0.00 0.00 0.00 0.01 0.06 0.04 0.03 0.02 0.024
Margin Stability 0.98 0.99 0.99 0.99 0.99 0.99 0.97 0.96 0.96 0.96 0.95 0.95 0.95 0.95 0.95 0.95 0.95 0.96 0.96 0.96 0.961
Rev. Growth Consistency 0.00 1.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.88 0.92 1.00 0.97 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.50 0.81 0.88 0.94 0.50 0.50 0.50 0.84 0.837
Earnings Smoothness 0.66 0.77 0.99 0.92 0.00 0.00 0.07 0.00 0.19 0.00 0.00 0.00 0.17 0.37 0.65 0.84 0.25 0.24 0.40 0.66 0.661
ROE Trend -0.12 -0.09 -0.05 -0.10 1.18 1.06 0.90 0.93 -0.46 -0.49 -0.46 -0.47 -0.83 -0.70 -0.56 -0.52 0.02 0.07 0.05 0.02 0.019
Gross Margin Trend 0.01 0.01 -0.01 -0.01 -0.01 0.01 0.04 0.05 0.06 0.06 0.05 0.05 0.04 0.02 0.00 -0.00 0.00 0.01 0.01 0.01 0.014
FCF Margin Trend -0.04 -0.03 0.02 0.05 0.05 -0.00 -0.09 -0.09 -0.07 -0.02 0.02 0.00 -0.02 -0.04 -0.01 0.03 0.06 0.07 0.05 0.06 0.062
Sustainable Growth Rate 3.5% 4.0% 8.4% 4.7% 85.0% 89.3% 82.4% 88.9% 33.3% 22.4% 17.3% 12.4% 0.8% 1.0% 4.8% 6.4% 18.0% 19.3% 18.6% 11.8% 11.79%
Internal Growth Rate 0.7% 0.7% 1.6% 0.9% 17.7% 19.7% 18.4% 21.1% 6.5% 4.7% 3.9% 2.9% 0.2% 0.2% 1.1% 1.6% 4.8% 5.0% 5.1% 3.3% 3.26%
Cash Flow Quality
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
OCF/Net Income 1.78 1.73 1.91 2.21 0.65 0.50 0.34 0.30 0.91 1.33 1.66 1.74 2.77 2.45 2.06 2.26 1.56 1.46 1.43 1.82 1.818
FCF/OCF 0.61 0.63 0.69 0.72 0.77 0.69 0.56 0.50 0.58 0.64 0.68 0.67 0.62 0.53 0.56 0.60 0.69 0.75 0.75 0.80 0.798
FCF/Net Income snapshot only 1.451
OCF/EBITDA snapshot only 0.821
CapEx/Revenue 9.4% 8.6% 8.7% 8.3% 6.3% 7.1% 7.5% 7.8% 7.8% 7.7% 7.7% 7.3% 8.4% 9.5% 9.1% 9.7% 8.2% 6.4% 6.3% 5.3% 5.33%
CapEx/Depreciation snapshot only 0.799
Accruals Ratio -0.04 -0.04 -0.06 -0.07 0.07 0.11 0.13 0.15 0.01 -0.03 -0.05 -0.05 -0.07 -0.06 -0.06 -0.07 -0.05 -0.04 -0.04 -0.07 -0.065
Sloan Accruals snapshot only -0.057
Cash Flow Adequacy snapshot only 1.871
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Dividend Yield — — — — — — — — — — — — — — — — 3.2% — — — 3.54%
Dividend/Share $0.99 $0.98 $0.98 $0.79 $0.92 $0.85 $0.75 $0.60 $0.57 $0.55 $0.55 $0.57 $0.59 $0.60 $0.60 $0.61 $0.68 $0.69 $0.70 $0.72 $0.68
Payout Ratio 88.5% 87.2% 75.4% 84.3% 26.5% 23.2% 21.0% 16.0% 38.6% 45.6% 50.4% 58.4% 95.6% 94.9% 78.9% 72.8% 50.7% 49.3% 48.9% 60.5% 60.49%
FCF Payout Ratio 81.6% 79.6% 57.3% 53.0% 52.8% 67.4% 1.1% 1.1% 73.7% 53.5% 44.7% 49.9% 55.6% 73.6% 68.3% 53.4% 46.8% 44.9% 45.4% 41.7% 41.68%
Total Payout Ratio 88.5% 87.2% 75.5% 84.4% 26.5% 23.3% 21.0% 16.1% 38.7% 45.6% 50.4% 58.4% 95.6% 94.9% 86.7% 96.4% 73.6% 71.3% 71.8% 82.9% 82.89%
Div. Increase Streak 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0
Chowder Number — — — — — — — — — — — — — — — — 0.19 — — — —
Buyback Yield — — — — — — — — — — — — — — — — 1.5% — — — —
Net Buyback Yield — — — — — — — — — — — — — — — — 1.4% — — — —
Total Shareholder Return — — — — — — — — — — — — — — — — 4.7% — — — —
DuPont Factors
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Tax Burden (NI/EBT) 0.85 0.89 0.91 0.86 2.95 2.60 2.69 2.36 0.83 0.81 0.81 0.80 0.76 0.74 0.75 0.74 0.78 0.77 0.78 0.82 0.817
Interest Burden (EBT/EBIT) 0.98 0.98 1.00 0.98 0.88 0.89 0.87 0.89 0.90 0.89 0.89 0.88 0.84 0.85 0.87 0.88 0.91 0.91 0.91 0.70 0.698
EBIT Margin 0.16 0.15 0.16 0.16 0.16 0.20 0.22 0.25 0.27 0.22 0.20 0.18 0.13 0.13 0.15 0.17 0.24 0.25 0.25 0.25 0.255
Asset Turnover 0.42 0.43 0.43 0.43 0.49 0.46 0.39 0.40 0.49 0.51 0.52 0.54 0.53 0.53 0.53 0.54 0.54 0.54 0.53 0.55 0.551
Equity Multiplier 5.37 5.38 5.40 5.23 5.66 5.43 5.30 5.11 5.44 4.98 4.56 4.34 4.38 4.38 4.26 4.02 3.96 4.01 3.86 3.73 3.731
Per Share
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
EPS (Diluted TTM) $1.11 $1.13 $1.31 $0.94 $3.48 $3.65 $3.58 $3.76 $1.47 $1.20 $1.09 $0.98 $0.62 $0.63 $0.76 $0.83 $1.34 $1.40 $1.43 $1.19 $1.19
Book Value/Share $3.81 $3.69 $3.98 $3.22 $2.24 $2.59 $2.89 $3.10 $3.19 $3.24 $3.36 $3.49 $3.43 $3.35 $3.42 $3.60 $3.94 $4.01 $4.38 $4.31 $4.28
Tangible Book/Share $-6.26 $-6.28 $-6.15 $-0.18 $-3.33 $-2.64 $-2.25 $-2.33 $-2.22 $-2.00 $-2.14 $-1.96 $-1.88 $-2.16 $-2.18 $-1.78 $-1.91 $-1.81 $-1.86 $-1.60 $-1.60
Revenue/Share $8.22 $8.37 $8.97 $6.95 $8.33 $7.81 $7.12 $7.17 $7.21 $7.37 $7.47 $7.63 $7.67 $7.69 $7.62 $7.70 $7.84 $7.99 $8.05 $8.17 $8.27
FCF/Share $1.21 $1.23 $1.72 $1.49 $1.74 $1.26 $0.67 $0.56 $0.77 $1.02 $1.23 $1.14 $1.06 $0.81 $0.88 $1.14 $1.45 $1.54 $1.54 $1.72 $1.43
OCF/Share $1.98 $1.95 $2.50 $2.07 $2.27 $1.81 $1.20 $1.12 $1.33 $1.59 $1.81 $1.70 $1.70 $1.55 $1.57 $1.88 $2.10 $2.05 $2.05 $2.16 $1.99
Cash/Share $0.87 $1.06 $3.44 $1.29 $1.75 $1.93 $1.71 $1.59 $1.63 $1.26 $1.00 $0.72 $0.79 $0.91 $1.08 $0.88 $0.81 $0.83 $0.85 $0.76 $0.77
EBITDA/Share $2.60 $2.02 $2.18 $1.73 $1.96 $2.07 $2.08 $2.29 $2.38 $2.47 $2.30 $2.22 $1.91 $1.63 $1.86 $2.10 $2.63 $2.84 $2.77 $2.63 $2.63
Debt/Share $6.32 $5.93 $8.20 $4.35 $5.41 $5.14 $5.12 $5.25 $5.07 $4.38 $4.32 $4.11 $3.94 $4.16 $4.46 $0.00 $4.33 $4.34 $4.69 $4.46 $4.46
Net Debt/Share $5.45 $4.87 $4.76 $3.07 $3.66 $3.21 $3.41 $3.66 $3.44 $3.12 $3.33 $3.39 $3.15 $3.25 $3.37 $-0.88 $3.52 $3.50 $3.84 $3.70 $3.70
Academic Models
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — —
Piotroski F-Score 5 5 5 7 6 6 5 5 4 5 6 6 6 6 7 6 6 7 7 7 7
Beneish M-Score -2.71 -2.55 -2.42 -2.99 -2.27 -2.21 -2.11 -1.47 -2.35 -3.46 -2.68 -2.64 -3.05 -32.46 -2.70 -2.79 -2.57 -2.41 -2.56 -2.69 -2.686
Ohlson O-Score snapshot only -7.530
Net-Net WC snapshot only $-6.60
EVA snapshot only $2390301374.82
Credit
Metric Trend Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Current
Credit Rating snapshot only A
Credit Score 54.95 54.50 57.90 67.00 62.00 58.35 56.85 56.85 59.95 60.85 61.45 61.45 57.45 54.60 58.45 64.35 72.50 72.50 72.50 72.50 72.500
Credit Grade snapshot only 6
Credit Trend snapshot only 8.150
Implied Spread (bps) snapshot only 150.000

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms